TEVA vs. BAP
TEVA (Teva Pharmaceutical Industries Limited) and BAP (Credicorp Ltd.) are both stocks. TEVA operates in Drug Manufacturers - Specialty & Generic (Healthcare), while BAP operates in Banks - Regional (Financial Services). Over the past 10 years, TEVA returned -3.83%/yr vs 14.76%/yr for BAP. At a 0.18 correlation, their price movements are largely independent.
Performance
TEVA vs. BAP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TEVA achieves a 10.96% return, which is significantly lower than BAP's 34.85% return. Over the past 10 years, TEVA has underperformed BAP with an annualized return of -3.83%, while BAP has yielded a comparatively higher 14.76% annualized return.
TEVA
- 1D
- 0.20%
- 1M
- -4.47%
- YTD
- 10.96%
- 6M
- 16.25%
- 1Y
- 95.54%
- 3Y*
- 66.30%
- 5Y*
- 25.53%
- 10Y*
- -3.83%
BAP
- 1D
- 0.32%
- 1M
- 21.83%
- YTD
- 34.85%
- 6M
- 36.98%
- 1Y
- 77.15%
- 3Y*
- 45.10%
- 5Y*
- 30.93%
- 10Y*
- 14.76%
TEVA vs. BAP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TEVA Teva Pharmaceutical Industries Limited | 10.96% | 41.61% | 111.11% | 14.47% | 13.86% | -16.99% | -1.53% | -36.45% | -18.63% | -46.18% |
BAP Credicorp Ltd. | 34.85% | 65.23% | 31.35% | 16.29% | 14.47% | -24.73% | -17.56% | -0.26% | 8.91% | 37.84% |
Correlation
The correlation between TEVA and BAP is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Oct 25, 1995 | 0.18 |
The correlation between TEVA and BAP shifts across timeframes, from 0.16 (3 years) to 0.31 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
TEVA:
$40.83B
BAP:
$27.79B
TEVA:
$1.34
BAP:
PEN 90.36
TEVA:
25.89
BAP:
3.87
TEVA:
0.20
BAP:
0.21
TEVA:
2.33
BAP:
0.97
TEVA:
4.96
BAP:
0.72
TEVA:
$17.35B
BAP:
PEN 28.76B
TEVA:
$9.03B
BAP:
PEN 22.06B
TEVA:
$3.05B
BAP:
PEN 11.19B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TEVA vs. BAP — Risk / Return Rank
TEVA
BAP
TEVA vs. BAP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and Credicorp Ltd. (BAP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TEVA | BAP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.08 | ||
| Sortino ratioReturn per unit of downside risk | +0.67 | ||
| Omega ratioGain probability vs. loss probability | 1.47 | 1.43 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 4.41 | 4.94 | -0.53 |
| Martin ratioReturn relative to average drawdown | 12.66 | 10.91 | +1.75 |
Loading charts...
Drawdowns
TEVA vs. BAP - Drawdown Comparison
The maximum TEVA drawdown since its inception was -90.89%, which is greater than BAP's maximum drawdown of -75.92%. Use the drawdown chart below to compare losses from any high point for TEVA and BAP.
Loading charts...
Drawdown Indicators
| TEVA | BAP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.89% | -75.92% | -14.97% |
Max Drawdown (1Y)Largest decline over 1 year | -21.79% | -15.71% | -6.08% |
Max Drawdown (3Y)Largest decline over 3 years | -43.70% | -26.53% | -17.17% |
Max Drawdown (5Y)Largest decline over 5 years | -43.70% | -33.40% | -10.30% |
Max Drawdown (10Y)Largest decline over 10 years | -88.41% | -59.09% | -29.32% |
Current DrawdownCurrent decline from peak | -48.81% | 0.00% | -48.81% |
Average DrawdownAverage peak-to-trough decline | -32.00% | -23.93% | -8.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.72% | 7.09% | +0.63% |
Volatility
TEVA vs. BAP - Volatility Comparison
The current volatility for Teva Pharmaceutical Industries Limited (TEVA) is 10.61%, while Credicorp Ltd. (BAP) has a volatility of 15.39%. This indicates that TEVA experiences smaller price fluctuations and is considered to be less risky than BAP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TEVA | BAP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.61% | 15.39% | -4.78% |
Volatility (6M)Calculated over the trailing 6-month period | 23.72% | 28.90% | -5.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 39.04% | 32.59% | +6.45% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.82% | 31.63% | +11.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 47.35% | 31.20% | +16.15% |
Dividends
TEVA vs. BAP - Dividend Comparison
TEVA has not paid dividends to shareholders, while BAP's dividend yield for the trailing twelve months is around 0.42%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BAP Credicorp Ltd. | 3.86% | 3.78% | 6.65% | 4.52% | 2.84% | 0.99% | 5.37% | 3.95% | 1.94% | 4.16% | 1.47% | 2.25% |
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.88% | 3.19% | 1.77% |
Financials
TEVA vs. BAP - Financials Comparison
This section allows you to compare key financial metrics between Teva Pharmaceutical Industries Limited and Credicorp Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TEVA vs. BAP - Profitability Comparison
TEVA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a gross profit of 1.97B and revenue of 3.98B. Therefore, the gross margin over that period was 49.5%.
BAP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Credicorp Ltd. reported a gross profit of 6.01B and revenue of 7.74B. Therefore, the gross margin over that period was 77.7%.
TEVA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported an operating income of 652.00M and revenue of 3.98B, resulting in an operating margin of 16.4%.
BAP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Credicorp Ltd. reported an operating income of 2.91B and revenue of 7.74B, resulting in an operating margin of 37.7%.
TEVA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a net income of 369.00M and revenue of 3.98B, resulting in a net margin of 9.3%.
BAP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Credicorp Ltd. reported a net income of 2.06B and revenue of 7.74B, resulting in a net margin of 26.6%.
Frequently Asked Questions
TEVA and BAP have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BAP has higher volatility (15.39%) compared to TEVA (10.61%). In terms of maximum drawdown, TEVA dropped -90.89% vs BAP's -75.92%.
TEVA currently has the higher Sharpe Ratio (2.46 vs 2.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TEVA and BAP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer